---

Highlights of August 2021

1. Serum Institute of India acquires 50% stake of SCHOTT Kaisha.
2. Mylab, Hemex Health ink tech partnership for PoC diagnostics.
3. Glenmark, SaNOtize in tie-up to commercialize NONS for COVID-19 treatment in Asian markets.
4. Cipla, Kemwell Enter Biosimilars Joint Venture Partnership to focus on developing, manufacturing and commercializing biosimilars.
5. Dr Reddy's Lab partners with B Medical systems to provide vaccine storage solution.
6. Zydus partners with CHEMI of Italy to launch Enoxaparin Sodium Injection in the US.
7. Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin.
8. India-based Panacea Infosec along with Panacea Bioedge has partnered with Healmed Solutions, to launch India’s first AI-based digital, touch-free, voice-enabled mental healthcare technology platform ‘Panacea Healmed’.
9. Sierra Oncology acquires AstraZeneca myelofibrosis drug.
10. NuChem Sciences acquires rival Canadian CRO OmegaChem.
11. Schrödinger inks cancer R&D deal with Zai Lab.
12. Orion signs agreement with Marinus Pharmaceuticals.
13. Takeda partners with Frazier to launch HilleVax.
14. Cereno Scientific has announced a collaboration agreement with Abbott regarding use of its CardioMEMS HF System in the upcoming Phase II study with Cereno’s drug candidate CS1.